CSPC Pharmaceutical Group (HKSE:01093) Other Current Payables : HK$5,648 Mil (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Other Current Payables?

CSPC Pharmaceutical Group's Other Current Payables for the quarter that ended in Dec. 2024 was HK$5,648 Mil.

CSPC Pharmaceutical Group's quarterly Other Current Payables declined from Jun. 2024 (HK$6,937 Mil) to Sep. 2024 (HK$0 Mil) but then increased from Sep. 2024 (HK$0 Mil) to Dec. 2024 (HK$5,648 Mil).

CSPC Pharmaceutical Group's annual Other Current Payables declined from Dec. 2022 (HK$5,884 Mil) to Dec. 2023 (HK$5,846 Mil) and declined from Dec. 2023 (HK$5,846 Mil) to Dec. 2024 (HK$5,648 Mil).

CSPC Pharmaceutical Group Other Current Payables Historical Data

The historical data trend for CSPC Pharmaceutical Group's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Other Current Payables Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Payables

Get a 7-Day Free Trial

4,245.20

5,578.69

5,884.01

5,845.82

5,647.71

CSPC Pharmaceutical Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Payables	Get a 7-Day Free Trial															-	6,936.89	-	5,647.71	-

CSPC Pharmaceutical Group Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

CSPC Pharmaceutical Group Other Current Payables Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Cai Dong Chen	2201 Interest of corporation controlled by you
True Ally Holdings Limited	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Blackrock, Inc.	2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si	2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si	2101 Beneficial owner

CSPC Pharmaceutical Group Headlines

No Headlines